 JERSEY, Channel Islands, Oct. 01, 2021 GLOBE NEWSWIRE -- Quotient Limited NASDAQ:QTNT, a commercial-stage diagnostics company the Company, today announced the launch of the review process of the Expanded Immunohematology IH technical file dossier for review by the European notified body. The Company submitted part I of the dossier in September as planned. 